Allergy and Asthma Clinical Research, Inc.

Walnut Creek, California 94598

0 studies enrolling now · 19 studies all time

What they study most

Allergy, Peanut, Angioedema, Asthma, COPD, Hereditary Angioedema, Lung Diseases, Obstructive, Peanut Allergy, Perennial Allergic Rhinitis, Pulmonary Disease, Chronic Obstructive, Refractory or Unexplained Chronic Cough, Seasonal Allergic Rhinitis, Urticaria

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough — Running, not enrolling
• Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy — Stopped early
• A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor — Completed
• A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) — Completed
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma — Completed
• Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) — Completed
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration — Completed
• C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks — Completed
• C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks — Completed
• Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks — Completed
• Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks — Completed
• Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects — Completed
• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria — Completed
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies — Completed
• A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL — Completed